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Abstract
Background Health fluctuations even within a single day are typical in multiple sclerosis (MS), but are not captured by 
widely used questionnaires like the EQ-5D-5L. This exploratory study aimed to develop an ambulatory assessment (AA) 
version of the EQ-5D-5L (EQ-5D-AA) where patients rate their health on mobile phones multiple times per day over several 
days, and to assess its feasibility and face validity.
Methods An initial EQ-5D-AA version was based on two patient focus groups. It was then tested and continuously developed 
in an iterative process: patients completed it over several days, followed by debriefing interviews. Findings were used to 
refine the EQ-5D-AA, with the resulting version being tested by the subsequent wave of patients until participants declared 
no need for changes anymore. Before and after the AA period, participants completed the standard paper-based EQ-5D-5L 
asking about ‘today’.
Results Focus group participants reported that their impairments often fluctuated between and within days. They regarded 
an AA with three assessments per day over seven days most appropriate; assessment should be retrospective to the previous 
assessment, but not all items should be assessed at each time point. Four waves of AA testing were conducted. Thirteen out of 
the 17 participants preferred the AA over standard assessment as they regarded it more informative, but not too burdensome.
Conclusion The newly developed one-week AA of the EQ-5D-5L captures within-day and day-to-day health fluctuations in 
people with MS. From the patients’ perspective, it is a feasible and face valid way to provide important information beyond 
what is captured by the standard EQ-5D-5L.
Keywords EQ-5D · Health-related quality of life · Ambulatory assessment · Ecological momentary assessment · 
Instrument development · Multiple sclerosis
Plain English summary
People with the neurological disease multiple sclerosis (MS) 
have different symptoms and impairments that can reduce 
their quality of life. These impairments are often not con-
stantly present but change within a day or from one day 
to another. Measuring these changes might help clinicians 
treat people with MS better, and it might also be useful in 
studies, for example those investigating the effectiveness of 
MS medications. Therefore, we developed a way to meas-
ure the fluctuations in these patients’ everyday lives, using 
mobile phones. First, we discussed with a group of patients 
how the instrument should look. Second, we developed a 
first version of the instrument, which was tested by patients 
and then refined. In the new instrument, patients answer 
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questions about their health three times a day over nine days 
on their mobile phones. The questions were taken from the 
EQ-5D-5L questionnaire, which is a well-established instru-
ment measuring health-related quality of life. The questions 
covered mobility, self-care, usual activities, pain/discom-
fort and anxiety/depression, as well as a 0–100 scale where 
patients rate their subjective health. Our study participants 
found the new instrument feasible and useful.
Introduction
Multiple sclerosis (MS) is a chronic, currently uncurable, 
inflammatory disease of the central nervous system char-
acterised by clinically significant fluctuations in symptoms 
and functioning. MS frequently affects vision, mobility, cog-
nition, bladder control and other functions [1]. The most 
frequent MS phenotype is relapsing–remitting, followed 
by secondary and primary progressive disease course [2]. 
In relapsing–remitting MS, symptoms worsen during the 
clinical episodes (relapses) and last for a period of weeks 
to months [3]. However, symptoms also fluctuate at shorter 
intervals within a single day [4, 5] and from one day to the 
next [6]. For example, in fatigue, a frequent MS symptom, 
35.5% of variability could be attributed to moment-to-
moment fluctuations, 8.2% to day-to-day changes and 56.6% 
to individual differences [7].
The vast majority of patient-reported outcomes measures 
(PROMs) do not assess fluctuation but ask for the extent 
of impairment within a specific period like “the last seven 
days” or “today”. To choose a response option, respondents 
must summarise their experience within the reference period 
to form some kind of average or typical value. For example, 
a person may rate pain that is mild in the morning but gets 
more severe over the day as “moderate” as this represents the 
average intensity; another person in the same situation may 
choose “severe” as this represents the maximum.
However, information on short-term fluctuation is crucial 
for the understanding of impairments in MS. In addition 
to considerable diurnal variability within persons, temporal 
patterns differ between persons. Furthermore, fluctuation 
data within a single day can help uncover the interrelation 
between different impairments, as associations between 
symptoms were found predominantly within a day with lit-
tle carry-over effect from one day to the next [8]. In clinical 
practice, information on these fluctuations is highly relevant 
for rehabilitation, medication adjustment and life planning. 
For example, spasticity substantially fluctuates depending 
on time of the day, activity level, temperature, but also psy-
chological factors. A sensitive assessment of impairments 
related to this symptom can help to adjust dosing of antispas-
tic agents which have also substantial side effects.
Fluctuations can be captured by a method called ambula-
tory assessment (AA) where respondents provide informa-
tion on mobile devices multiple times per day over several 
days [9, 10]. In addition to capturing within-person dynam-
ics, AA reduces the need for respondents to average their 
health problems over longer periods of time, reduces recall 
bias, and can be assessed in everyday life, thereby providing 
high external validity [11]. As a drawback, AA increases 
response burden. Moreover, when repeatedly answering the 
same questions and thereby gaining experience with the 
surveyed construct, respondents may adjust their responses 
to the rating scale. Their answers will thus not be fully 
comparable anymore, a phenomenon known as recalibra-
tion response shift [12]. AA is increasingly being used in 
PROMs [13, 14] where it has been found to be feasible and 
valid [13, 15].
One of the most widely used PROMs is the EQ-5D-5L, 
a generic instrument of health status [16, 17]. Its first part, 
the EQ-5D descriptive system, includes five items (one 
per dimension) assessing mobility, self-care, usual activi-
ties, pain/discomfort and anxiety/depression, each with five 
response options representing different levels of severity 
[18]. The second part, EQ VAS, measures self-rated health 
with a horizontal visual analogue scale (VAS), the anchors 
labelled “The best health you can imagine” (100) and “The 
worst health you can imagine” (0). Both parts refer to health 
“today” without differentiating by time of day. The EQ-
5D-5L has replaced the previous version EQ-5D-3L that 
had only three response options, hoping to decrease the 
considerable ceiling effects. These are still found for the 5L 
version in the general population, but less so in people with 
increased morbidity [19, 20].
Psychometric properties of the EQ-5D-5L have been 
investigated in people with MS (PwMS), finding good 
test–retest reliability and convergent validity, but limited 
content validity and discriminative ability [21]. In other 
chronic diseases, it has also been found that the EQ-5D 
misses some relevant aspects of health-related quality of 
life; for example, fatigue [22]. We nonetheless decided to 
use the EQ-5D-5L in this study because of its combination 
of widespread use and brevity, the latter being crucial for 
feasibility in an AA.
The EQ-5D-5L also captures dimensions of health that 
are highly relevant in MS: Persons with relapsing-remitting 
MS reported “some” or “extreme” problems in mobility 
(68.9%), self-care (38.2%), usual activities (77.9%), pain/
discomfort (63.9%) and anxiety/depression (58.5%) (using 
the former, three-level EQ-5D version) [23]. When currently 
in a relapse, the number of PwMS who experience problems 
was found to be even higher with 55 to 94% by dimension 
[24].
To our knowledge only two other studies have meas-
ured within-day fluctuations with adapted versions of the 
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EQ-5D-5L, both in non-MS patient groups. In Kerr et al. 
2016, persons with Parkinson’s disease completed the EQ-
5D-5L both for “on-time” (where medication is working 
well) and “off-time” (where it does not), reporting also the 
duration of both states [25]. Considerable within-day fluc-
tuations were found. With MS, however, it is not as clear cut 
as good/bad, calling for a different approach to capturing 
health dynamics. In the second study, a momentary version 
of the EQ VAS with 10 assessments per day has successfully 
been tested in three patient groups and healthy people [26]. 
They found that average AA ratings correlated with, but also 
significantly differed from, the standard EQ VAS as assessed 
after the AA period and may therefore provide important 
additional information. The EQ-5D descriptive system was 
not included in that study.
To enable the measurement of health fluctuations in 
PwMS, we therefore aimed to develop an AA version of 
the complete EQ-5D-5L (called EQ-5D-AA, for ambula-
tory assessment of the EQ-5D) for use in this patient group. 
As an AA implies higher response burden than a one-time 
questionnaire, we also aimed to assess the EQ-5D-AA’s fea-
sibility and its face validity from the patient perspective as 
compared to the standard EQ-5D-5L. This study focuses 
only on the EQ-5D as a measure of health in research and 
clinical practice, not on its role as a tool for economic evalu-
ation for which it is frequently used.
Methods
This was a qualitative descriptive study [27] involving focus 
groups and one-on-one, in-person or telephone interviews 
with additional exploratory quantitative analyses. It included 
two phases: (a) the use of patient focus groups, resulting in 
a first version of the EQ-5D-AA and (b) completion of the 
EQ-5D-AA by subsequent waves of PwMS, each followed 
by cognitive debriefing and refinement of the instrument 
(Fig. 1).
Participants were recruited at the MS outpatient clinic 
at the University Medical Center Hamburg-Eppendorf and 
through MS self-help groups (newsletter and posting). Inclu-
sion criteria were: age ≥ 18 years, confirmed MS diagno-
sis, fluent in German, and sufficient cognitive and physi-
cal ability. The study sample should be heterogeneous with 
regard to disease severity, cognitive impairment and age, and 
should include both men and women. Participants received 
financial reimbursement.
Focus groups
In the two focus groups, we introduced participants to the 
EQ-5D-5L and the concept of AA. We asked them to report 
on the extent and pattern of fluctuation they experienced in 
each EQ-5D-5L dimension both within and between days. 
They also discussed which AA specifications would be opti-
mal to capture these fluctuations, like number of assessments 
per day, time points of data collection and retrospective vs. 
concurrent assessment, taking ease of administration into 
consideration.
Participant characteristics were assessed with a self-
completion questionnaire, including sociodemographic and 
clinical data, EQ-5D-5L and Perceived Deficits Question-
naire (PDQ-20 [28]) on cognitive impairment.
Audio recordings of focus group sessions were tran-
scribed verbatim. The qualitative approach used here was 
iterative thematic analysis. For this, we extracted all text 
passages potentially relevant for the research questions. 
Each extract was translated to English (for the international 
research group) by two members of the German team and 
summarised, and extracts were grouped by theme; addition-
ally, each theme was summarised separately. Based on these 
findings, the research group achieved consensus on specifi-
cations of the first version of the EQ-5D-AA; the research 
group included experts on EQ-5D-5L, PROMs, MS and 
qualitative methodology. Specifications were implemented 
Fig. 1  Flow chart of study procedures; PwMS, people with multiple 
sclerosis; EQ-5D-AA, ambulatory assessment of the EQ-5D-5L
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in movisensXS (Movisens GmbH, Karlsruhe, Germany), 
an app specifically developed for AA studies. EQ-5D was 
modified by the authors with permission by the EuroQol 
Research Foundation.
AA testing and cognitive debriefing
The EQ-5D-AA was tested by four subsequent waves of 
three to six PwMS, followed by individual debriefing inter-
views. After each wave, we refined the AA according to par-
ticipant feedback, with the resulting version being tested by 
the subsequent wave of PwMS. The sample size was guided 
by the concept of information power [29], that is, additional 
waves were conducted until no need for changes to the AA 
emerged anymore.
In detail, procedures were as follows. In a face-to-face 
meeting, participants familiarised themselves with the soft-
ware using a test version. The EQ-5D-AA was installed on 
the participant’s own Android smartphone or a loan unit 
(Samsung Galaxy A3), at the participant’s option. They com-
pleted the standard paper-based EQ-5D-5L about “today” 
and a questionnaire on sociodemographic and clinical data. 
During the following seven (in later waves, nine) days, they 
completed the EQ-5D-AA three times a day.
After the AA period, participants again completed the 
standard paper-based EQ-5D-5L.
In a subsequent debriefing, we interviewed each partici-
pant on feasibility of the EQ-5D-AA. Interviews were con-
ducted in person or by phone, if needed. We used a pilot-
tested interview guideline covering the following themes: 
feasibility and appropriateness of number of assessments 
per day and time points of data collection; feasibility and 
appropriateness of item wording; feasibility completing the 
AA for seven (or nine) days; face validity and preference for 
either AA or standard EQ-5D-5L; any further comments or 
suggestions for the EQ-5D-AA (Online Appendix 2).
For investigation of face validity, participants of the 
in-person interviews were presented their individual EQ-
5D-AA patterns displayed graphically along with their com-
pleted baseline paper EQ-5D-5L. Participants were asked 
whether and why they believed the AA data provided (or 
did not provide) important information about their health 
beyond the one-time assessment.
Analytical procedures were the same as in the focus 
group analysis (transcription, extracting and summarising, 
discussion with research group). In discussing the findings, 
focus group findings were also considered if pertinent to the 
respective theme. We used the results from each wave of 
debriefings to refine the EQ-5D-AA, which was then tested 
in the subsequent wave of participants. As we aimed to adopt 
only those changes that are needed specifically for an AA 
version but did not intend to optimise the EQ-5D-5L itself, 
no change suggestions relating exclusively to the instrument 
itself were considered.
Quantitative analyses
In exploratory quantitative analyses, the distribution of 
EQ-5D-AA responses was evaluated, including variability 
(number of participants with invariant responses; standard 
deviation (SD) of the EQ VAS), percentage of responses 
indicating no impairment, and graphical depiction of EQ 
VAS responses over the study period.
To test for agreement between standard and AA version, 
index scores were calculated for both the first assessment of 
EQ-5D-5L (at study inclusion) and the EQ-5D-AA, using 
the German value set [30]. For the EQ-5D-AA, scores were 
calculated separately per day and then averaged over days. 
In those items collected multiple times a day, the response 
indicating the highest impairment within that day was used. 
We did not calculate a score for each time point within the 
AA because not all EQ-5D items were collected at each time 
of the day. Agreement between scores based on EQ-5D-5L 
and EQ-5D-AA was determined using two-way mixed, aver-
age score, absolute agreement intra-class correlation (ICC). 
Agreement of average responses on single-item basis was 
evaluated descriptively only, as assumptions for ICC calcula-
tion were not met. For this, responses at study inclusion were 
averaged over participants, and EQ-5D-AA responses were 
first averaged over single assessments for each participant, 
then averaged over participants.
Results
Focus groups
The first focus group had 4 participants (1 male, 3 female), 
the second 5 (all male, Table 1). Both took place in August 
2019. Age ranged from 29 to 55 years. All participants were 
employed except for one in early retirement. Six out of 9 par-
ticipants had A-levels school education (i.e. 12 or 13 years 
of school education). MS types included relapsing-remitting 
(n = 6) and secondary progressive (n = 3); participants had 
been diagnosed with MS between 1 and 21 years before. 
The EQ-5D-5L index score ranged from 0.38 to 1.00 (1 rep-
resenting full health). EQ VAS ranged from 45 to 97 (100 
representing full health). Cognitive impairment was between 
0 and 35 on the PDQ-20 scale ranging from 0 (no impair-
ment) to 80 (highest impairment).
Focus group analysis resulted in eleven themes: one on 
each EQ-5D-5L item (including EQ VAS), one on retro-
spective versus momentary assessment, three on alerts at 
different times of day (morning, midday and evening), and 
one on options to postpone or silent alerts.
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Most participants agreed that the best way to measure 
the fluctuations they experienced was to assess retrospec-
tively to the previous assessment instead of for the cur-
rent moment (i.e. using a coverage strategy instead of a 
sampling strategy [15, 31]. They also agreed that ques-
tions should be asked for seven days at three times a day 
(morning, midday, evening), but not including all six 
items at each time point. For example, the EQ VAS should 
only be assessed in the evenings with regard to the time 
period since the previous evening as this was sufficient to 
describe overall health, while pain/discomfort should be 
assessed three times a day.
Participants differed in how much they reported their 
impairments to fluctuate, with some of them even report-
ing constant levels in some items: For example, one person 
who used a wheelchair was always unable to walk, and two 
persons never had any problems with self-care. However, for 
each item, most participants reported significant fluctuation 
within and/or between days.
Based on the focus group findings, specifications of the 
initial EQ-5D-AA version were derived.
AA testing and cognitive debriefing
The EQ-5D-AA testing was conducted between February 
and June 2019. Four waves were needed, including three, 
three, six and five participants (n = 17; 6 males, 11 females; 
age 21–63; three of them had participated in  the focus 
groups) (Table 1). Participants reported being employed 
(n = 7), in early retirement (n = 5), student/trainee (n = 3) or 
other (n = 2). The most frequent levels of school education 
were A-levels (n = 8) and secondary school certificate (n = 5; 
other, n = 4). MS types included relapsing–remitting, pri-
mary progressive and secondary progressive. Participants 
had received the MS diagnosis between two and thirty years 
before. EQ VAS ranged from 30 to 98, EQ-5D-5L index 
scores from 0.35 to 1.00. Cognitive impairment ranged from 
0 to 46 on the PDQ-20 scale of 0–80.
Table 1  Participant characteristics
a Range: 0 (worst health you can imagine) to 100 (best health you can imagine)
b According to the German value set [30]
c Range 0 (no impairment) to 80 (highest impairment)





Age: mean (SD), range 39.5 (9.8), 30–55 (n = 1 not answered) 45.6 (14.1), 21–63
Gender: n (%)
 Female 3 (33.3%) 11 (64.7%)
 Male 6 (66.7%) 6 (35.3%)
School education degree: n (%)
 General education (9 years) 0 (0%) 1 (5.9%)
 Middle school (10 years) 1 (11.1%) 6 (35.3%)
 Higher education (12 or 13 years) 7 (77.8%) 9 (52.9%)
 Other (not specified) 1 (11.1%) 1 (5.9%)
Job situation: n (%)
 Employed 8 (88.9%) 7 (41.2%)
 Early retirement 1 (11.1%) 5 (29.4%)
 Retirement 0 (0%) 1 (5.9%)
 Student / trainee 0 (0%) 3 (17.6%)
 Unemployed 0 (0%) 1 (5.9%)
Type of multiple sclerosis: n (%)
 Relapsing–remitting 6 (66.7%) 8 (47.1%)
 Primary progressive 0 (0%) 2 (11.8%)
 Secondary progressive 3 (33.3%) 7 (41.2%)
Years since first diagnosis of MS: mean (SD), range 10.1 (6.8), 2–22 14.6 (8.9), 2–30
EQ VAS on subjective health  statusa: mean (SD), range 74.9 (16.8), 55–97 73.0 (18.8), 30–98
EQ-5D-5L index  scoreb: mean (SD), range 0.79 (0.19), 0.38–0.94 0.76 (0.20), 0.35–1.00
PDQ global score on cognitive  impairmentc: mean (SD), range 18.1 (11.3), 0–34 25.1 (13.6), 0–46 
(n = 1 not answered)
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After the first, second and third wave, substantive changes 
were made to the EQ-5D-AA. For example, the assessment 
of depression/anxiety was changed from one to three times a 
day, and we added an option to do the midday alert earlier if 
the person is going to take a nap. The results from the fourth 
wave suggested only one minor change, which did not war-
rant an additional wave of testing: A "Good day" and "Good 
evening" page should be added to the midday and evening 
alert, respectively. There were also specifications of the EQ-
5D-AA for which the debriefing interviews did not suggest a 
need for changes, for example the frequency of assessments 
(i.e. three times a day).
Specifications of the final EQ-5D-AA version are listed 
in detail in Table 2 along with rationales, example citations 
from either focus groups or cognitive debriefings, and the 
preceding version, if applicable. Minor modifications of the 
AA wording are not listed, for example changing the morn-
ing instruction from “… last night” to “… since yesterday 
evening”. Screenshots of the final German EQ-5D-AA with 
translations to UK English are shown in Online Appendix 1. 
Briefly, the final EQ-5D-AA version assesses EQ-5D-5L 
items three times a day over a period of seven days, pre-
ceded by a familiarisation phase of two days. Participants are 
reminded of item completion by a repeated alarm. Morning 
and evening times are specified individually as the earliest 
and the latest time the participant is usually awake; the mid-
day time is the exact middle between these two time points. 
The morning assessment time can be defined differently 
for weekdays vs. Saturday/Sunday. Mobility, pain/discom-
fort and anxiety/depression are assessed three times a day, 
mainly because participants considered these to be highly 
fluctuating. Usual activities are assessed at midday and in 
the evening, self-care and EQ VAS in the evening only. Par-
ticipants can prepone both the midday and the evening alert 
so that the AA will not interfere with sleep.
Feasibility of the EQ‑5D‑AA
Asked to elaborate on feasibility in the debriefing interviews, 
most participants evaluated the EQ-5D-AA as short, easy, 
comprehensible and fine to handle:
Female, 57 years: “For me, that was okay. I did not feel 
bothered in any way. (…) It could easily be integrated 
into the changing everyday life that I have. (…) It does 
not take long, (…) one minute maximum.”
Male, 51 years: “I was doing fine with it. The questions 
are clearly worded so that you know what is asked for.”
Female, 62 years: “I got along well. (…) I only feared 
it could wake up my neighbour. (…) There also have 
been no difficulties with the mobile (which I had feared 
in the beginning), because the questions were always 
the same.”
However, some participants found the alerts to be annoy-
ing in some situations, and some could not respond at all 
times and therefore missed or postponed alerts:
Female, 28 years: “It was actually quite pleasant. 
Though sometimes I was interrupted in my daily hab-
its, when suddenly the mobile rings and you’re like: 
No! Silence, silence, silence!”
Female, 57 years: “Those two times or so that I forgot 
… not forgot, but too late … I think that wasn’t so 
dramatic.”
Occasionally, technical problems occurred (e.g. having 
to restart the study within the app; irrelevant warnings dis-
played by the app).
Missing values
While seven participants responded to each alert, ten partici-
pants missed between one and ten alerts. This corresponds 
to 0–45.5% missing responses per person (mean: 7.4%). No 
single items were missing, that is, whenever participants 
responded to an alert, they answered all items. In the inter-
views, participants stated as reasons for non-response being 
busy at work or doing leisure activities, sleeping, forgetting 
to switch on the phone, not taking the lend device with them 
or accidentally choosing the ‘decline’ option.
Face validity
Asked how well the EQ-5D-AA represented their actual 
health during the respective week, 13 out of 17 participants 
thought that the AA was better in capturing health than the 
two assessments with the standard EQ-5D-5L before and 
after the AA period. Stated reasons were that the AA was 
more informative or precise, captured fluctuations better, 
evaluated more than two days (the latter being more of a 
snapshot), measured multiple times per day and provided 
the opportunity to get used to the questions.
One participant thought the two assessments were bet-
ter suited to depict health, but without being able to give a 
reason; one participant thought both methods were equally 
appropriate; and two did not make a clear statement on this 
question.
Variation in EQ‑5D‑AA items over time
In all five items of the EQ-5D descriptive system, the per-
centage of “no problems” responses in the AA was higher 
than 50% (averaged over participants; self-care: 66.3%; anxi-









Table 2  Specifications and rationale of the final EQ-5D-AA
EQ-5D-AA specification Rationale and/or reason for 
changing the preceding ver-
sion (if applicable)
EQ-5D-AA version in which 
this specification was intro-
duced
Sample quotation from study 
participants
Specification in preceding 
version (if applicable)
Sample quotation for the pre-
ceding version (if applicable)
Assessment is retrospective 
to the previous assess-
ment of the item (e.g. the 
morning alert refers to the 
time period since the last 
evening).
This way, the complete day 
and night will be covered. 
As some items are only 
pertinent at specific times 
of the day (e.g. self-care), 
momentary assessment is 
not reasonable.
1 FG 2: “I would spontane-
ously prefer to have a longer 
period of time. Maybe two, 
three times a day or so, 
because then, you would 
avoid that like short-term 
incidents, well, which can 
dominate the moment that 
would maybe lead to a dif-
ferent result from answer-
ing.”
n. a. n. a.
The exact assessment times 
are predefined individually 
for each participant at study 
onset.
Participants will not have to 
start the app actively, as this 
may be stressful and will 
probably be forgotten in 
many cases (based also on 
experience from a previous 
AA study). Individually 
defined times will take dif-
ferent bedtimes into account.
1 FG 2: “I guess it’s not my 
first thought directly after 
getting up to click into app 
on and say ‘I am awake’.” 
[Interviewer:] “Yes, actually 
that was our hope.” (Both 
laughing) [Participant:] 
“Yes, but I don’t think … “ 
[Interviewer: “It’s not real-
istic.”] [Other participant:] 
“Yes, I think so, too.”
n. a. n. a.
The morning assessment is 
defined as the earliest time 
the participant is usually 
awake.
The app will not wake the 
participant (if the phone is 
not on silent) and the alert 
will not be missed due to 
being asleep (if the phone is 
on silent).
1 FG 2: “But if having a 
specific time of the day is 
not relevant for you, but 
each person individually, 
then you can actually enter 
sleep and activity times in 
the app. Because that would 
of course guarantee that in 
the morning at that time, 
that I actually complete the 
questionnaire and will not 
forget it.”
n. a. n. a.
The evening assessment is 
defined as the latest time the 
participant is usually still 
awake. Participants will have 
the opportunity to prepone 
completion (i.e. initiate an 
earlier completion of the 
evening assessment).
This way, the evening alert 
will capture as much time 
as possible of afternoon and 
evening. However, when 
going to bed early, partici-
pants will not be woken up 
by the app or miss the even-
ing alert.
1 FG 2: “I don’t know, maybe 
one could define that 
beforehand: What does 
midday mean for me? What 
does evening mean for me?” 











Table 2  (continued)
EQ-5D-AA specification Rationale and/or reason for 
changing the preceding ver-
sion (if applicable)
EQ-5D-AA version in which 
this specification was intro-
duced
Sample quotation from study 
participants
Specification in preceding 
version (if applicable)
Sample quotation for the pre-
ceding version (if applicable)
The midday assessment is 
defined as the exact middle 
between the individual 
morning and evening alert 
times.
Two wave 1 participants sug-
gested to have the midday 
alert closer to the exact time 
point between morning and 
evening alert. This way, 
morning-midday interval 
and midday-evening interval 
will be more similar and the 
alert will be closer to mid-
day for many participants.
2 Wave 1: “You might do this 
exactly in the middle of 
the time between morn-
ing and evening. Because 
now, I had that at 5:30 pm, 
which I found a strange 
time (laughs) (…) for such 
a query.”
The midday alert was sent 
eight hours after the indi-
vidual morning alert.
FG 2: “Then I would say, after 
a certain amount of hours. 
Then you could actually 
adjust your daily routines.”
The morning assessment time 
can be defined differently for 
weekdays vs. the weekend.
Many people sleep longer 
at the weekend than on 
weekdays. This specification 
was not based on FG results 
but on the study group’s 
considerations.
1 n. a. n. a. n. a.
The mobility item is assessed 
three times a day.
It was discussed whether 
mobility assessment makes 
sense in the morning where 
it refers to the night. As 
people may have to go to 
the restroom during the 
night, the consensus was 
that the morning assessment 
should include mobility. 
Upon inquiry, participants 
of waves 1–4 did not raise 
objections against this.
1 Wave 3: “If you had asked 
me in the past, I would have 
said ’Oh my God, I really 
have big problems in the 
night’. (…) Because I used a 
rollator at that time. (…) So, 
I got out of bed, used the 
rollator to get to the toilet 
and sat down. And err, this 
was a dangerous time. All 
very error-prone.”
n. a. n. a
Within the morning alert, a 
page saying “Good morn-
ing!” is displayed before the 
items are asked.
This was suggested by a FG 
participant and was men-
tioned as being important by 
a wave 4 participant.
1 FG 2: “Couldn’t you program 










Table 2  (continued)
EQ-5D-AA specification Rationale and/or reason for 
changing the preceding ver-
sion (if applicable)
EQ-5D-AA version in which 
this specification was intro-
duced
Sample quotation from study 
participants
Specification in preceding 
version (if applicable)
Sample quotation for the pre-
ceding version (if applicable)
The pain/discomfort item is 
assessed three times a day.
In the FGs, all participants 
reported pain to fluctuate, 
either from day to day or 
within a day and sometimes 
quite quickly. Some partici-
pants reported pain to also 
occur in the night.
1 FG 1: “Well, before going to 
sleep, you usually focus on 
it (…) because suddenly 
you are alone with yourself. 
(…) And then you notice 
many things you did not 
notice during the day. And 
there are nights in which it 
massively prevents you from 
sleeping, from sleeping 
peacefully, from sleeping 
soundly. Sometimes, it takes 
it out of you so that you feel 
absolutely whacked the next 
morning.”
n. a. n. a
The anxiety/depression item is 
assessed three times a day.
Although some FG partici-
pants reported considerable 
fluctuation in depression/
anxiety also within the day, 
some of them expressed 
concern that an assessment 
more than once daily would 
be psychologically too 
burdensome. However, after 
changing the assessment 
from one to three times a 
day after wave 1, none of the 
participants of waves 2–4 
found this too burdensome.
2 Wave 2: "Especially since 
emotions can fluctuate 
extremely fast, I think that 
three times isn’t too much. 
(…) What strains me in the 
morning can be completely 
unimportant to me in the 
evening. (…).” [Inter-
viewer:] “And it wasn’t too 
burdensome to you, that you 
would say ’I don’t want to 
think about it three times 
a day’? As that was some 
people’s concern.” [Partici-
pant:] “I try to approach my 
life as reflected as possible. 
That means (…) actually I 
thought it was quite pleas-
ant, so to speak, ’Have I 
been annoyed by anything?’ 
(…) ’Can I do something 
about it?’ So, err, becoming 
aware of it.”
Depression was assessed only 
in the evenings, retrospec-
tive for the time since the 
evening assessment the day 
before
FG 1: “When you suddenly get 
a sensation of fear and, err or 
a feeling of being depressed, 
err, but in this moment, (…) I 
do not want to pose this ques-
tion that often during the day 
because then you focus on 
it.” (…) [Second participant:] 
“Yes!” [Third participant:] 
“Hmh. (approving)”. [First 
participant:] “And I think it 
would bring me to the point 
at which I do not want to do 
this anymore. (…) Because 
I am permanently reminded 
of it.” [Second participant:] 
“Yes. (…) I would say it is 
also something that might 
theoretically to some extent 
affect the daily activities. 











Table 2  (continued)
EQ-5D-AA specification Rationale and/or reason for 
changing the preceding ver-
sion (if applicable)
EQ-5D-AA version in which 
this specification was intro-
duced
Sample quotation from study 
participants
Specification in preceding 
version (if applicable)
Sample quotation for the pre-
ceding version (if applicable)
The usual activities item is 
assessed two times a day 
(midday, evening).
Assessing midday and even-
ing will cover the whole 
day. Activities will not be 
assessed in the morning, 
because ’usual activities’ 
mostly does not apply to the 
night.
1 FG 2: “They list a lot of daily 
activities here, for example. 
That means that you would 
somehow start in the morn-
ing. Then you go to work, 
for example, or studying and 
then you come home, do the 
chores and then you may 
have a leisure activity before 
or afterwards, so, the app 
could ask at many different 
times and ask if you have 
problems with it.”
n. a. n. a.
The self-care item is assessed 
once daily in the evening, 
retrospective for the time 
since the morning.
When self-care was assessed 
twice a day in the first AA 
version, participants handled 
the item differently: If they 
did not wash or dress in 
the afternoon, some would 
respond "no problems" in 
the evening alert while oth-
ers reported the problems 
they would, hypothetically, 
have had if they had washed 
or dressed themselves. 
Asking only once a day, 
referring to the whole day, 
shall ensure that for each 
participant their personal 
washing and dressing time 
will be covered so they need 
not respond hypothetically 
anymore.
3 Wave 2: “and then there was 
this ‘dressing and washing’ 
that showed twice somehow 
(…) that somehow didn’t 
make sense to me. (…) If 
you have regular work-
ing hours, maybe it would 
fit better, I don’t know.” 
[Interviewer:] “And do you 
remember which answer 
you chose in the evenings? 
(…)” [Participant:] “Mhm 
… more about my general 
condition with … moder-
ate. (…) or I thought ‘How 
would I have felt had I done 
that?’”
Self-care was assessed at mid-
day (retrospective for the 
time since morning) and in 
the evening (retrospective 
for the time since midday).
FG 1: “I would consider (…) 
hygiene rituals you have 










Table 2  (continued)
EQ-5D-AA specification Rationale and/or reason for 
changing the preceding ver-
sion (if applicable)
EQ-5D-AA version in which 
this specification was intro-
duced
Sample quotation from study 
participants
Specification in preceding 
version (if applicable)
Sample quotation for the pre-
ceding version (if applicable)
The EQ VAS is assessed once 
daily in the evening.
Some FG participants 
preferred a once daily retro-
spective assessment of the 
EQ VAS (as this was suffi-
cient and not as annoying as 
multiple assessments), while 
others could also imagine 
multiple assessments. We 
then decided on a once daily 
assessment. No participant 
of wave 1–4 suggested a 
more frequent assessment.
1 FG 2: “In this case I would 
wish, of course, that we 
query it once a day. (…) Not 
three times.” [Interviewer:] 
“That’s clear to you, ok.” 
[Participant:] “I would say 
that. Like reviewing the day, 
that you can manage that as, 
like, a resume."
n. a. n. a.
Participants can prepone the 
evening alert if they are 
going to bed early.
This option was introduced 
not based on FG results but 
based on experience with 
previous AA studies. The 
feature was used by many 
participants of waves 1–4.
1 n. a.
After using the option to 
prepone the evening alert 
or after responding to the 
regular evening alert, the 
option will not be displayed 
anymore until the next 
evening.
It caused confusion that the 
button for preponing the 
evening alert still showed 
after the participant had 
already answered the even-
ing questions.
2 Wave 1: “The only thing that 
confused me a bit was (…) 
I had answered the evening 
questions and then there 
was the option again, ‘if 
you wanna go to bed now’ 
and that of course I found 
a bit strange because I had 
already answered this ques-
tion. That you maybe set it 
like that this question won’t 
come anymore then.”
The button for preponing the 
evening alert still showed 
after the participant had 
already answered the even-
ing questions.
n. a.
Participants can prepone the 
midday alert if they are 
going to take a nap.
Participants will not be woken 
up from midday sleep if they 
do not think of putting the 
phone on silent (or are too 
conscientious to omit an 
alert and therefore did not 
want to silence the phone).
4 Wave 3: “Well, when I am 
working I leave the house 
at 7 and I come back at half 
past 2, 2 and I directly lie 
down and then I thought, 
’Oh, now I have to wait till 
three, so I need not take a 
nap now.’ I found that stupid 
somehow. So, I took the 
phone to bed with me and 
then it woke me up.”
No option to prepone the mid-
day alert was available.
n. a.
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51.4%; usual activities: 50.0%). Depending on the item, 
between three and seven of the 17 participants did not show 
any variation in the respective dimension. In all these cases, 
“no impairment” was reported, except for one participant 
who in the mobility item stated the highest possible impair-
ment (“unable to walk”) at all time points.
For the EQ VAS, variability differed markedly between 
participants with 0.7–24.7 SD. Figures 2 and 3 depict the 
individual EQ VAS courses over the assessment period 
(which was eight or ten days: participants used either 
the seven-day or the nine-day version, and the AA started 
already in the evening after study inclusion which added 
another VAS assessment). Figure 2 shows that participants 
with more stable responses (SD < 9, based on median split) 
could be in either good or bad health as measured with the 
EQ VAS. Figure 3 shows that in participants with higher 
variability (SD > 9), no clear pattern of increase or decrease 
over time is discernible.
Agreement between standard EQ‑5D‑5L 
and EQ‑5D‑AA
At a group level, agreement between index scores calcu-
lated for standard paper EQ-5D-5L at study inclusion and 
for EQ-5D-AA (averaged over days) was high with an ICC 
of 0.833. Agreement was also high for the EQ VAS with an 
ICC of 0.896. Looking at the single items on group level, 
participants reported slightly more problems in the standard 
version than in the AA (Table 3). On single participant level, 
the largest differences between the two assessments were 
found for mobility being rated up to 3.1 points worse on 
paper. Differences in the other direction, i.e. better health 
ratings in the AA than at study inclusion in single patients, 
were less pronounced with up to 0.65 points difference.
Discussion
In this study, we developed an AA version of the EQ-5D-5L 
for use in people with MS. After two focus groups and four 
waves of iterative testing and refining, the EQ-5D-AA was 
finalised. The AA was extended from seven to nine days due 
to participants reporting recalibration response shift within 
the first two days. Participants judged the AA as not too bur-
densome to complete for this duration and also considered 
it feasible. Most of them found it more informative than the 
standard one-time assessment of EQ-5D-5L.
There was high agreement between one-time assessment 
and average AA index scores in spite of intra-individual 
variability in AA responses. This shows that times in better 
and worse health evened out over the 7–10-day AA period. 
Descriptively, similar values were also found on single-item 
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Fig. 2  EQ VAS responses 
collected in the EQ-5D-AA, 
by participant and day of study 
(subsample: participants with a 
low variability (SD < 9) in the 
EQ VAS; each line represents 
one participant; n = 9) EQ VAS, 
visual analogue scale of the EQ-
5D-5L; SD, standard deviation; 
EQ-5D-AA, ambulatory assess-
ment of the EQ-5D-5L
Fig. 3  EQ VAS responses 
collected in the EQ-5D-AA, 
by participant and day of study 
(subsample: participants with a 
high variability (SD > 9) in the 
EQ VAS; each line represents 
one participant; n = 8) EQ VAS, 
visual analogue scale of the EQ-
5D-5L; SD, standard deviation; 
EQ-5D-AA, ambulatory assess-
ment of the EQ-5D-5L
Table 3  Descriptive comparison 
of standard paper EQ-5D-5L 
(collected at study inclusion) 
with EQ-5D-AA (averaged over 
single assessments for each 
participant)
a In the context of this exploratory analysis, we treated the ordinal EQ-5D-5L scores as having cardinal 
properties
b Positive values indicate higher values in the EQ-5D-5L than in the EQ-5D-AA





Individual difference between EQ-
5D-5L and EQ-5D-AAb
Minimum Maximum Mean
Mobility 2.65 2.00 3.08 − 0.18 0.64
Self-care 1.65 1.50 2.00 − 0.63 0.15
Usual activities 2.06 1.71 1.42 − 0.44 0.35
Pain/discomfort 2.12 1.70 1.92 − 0.14 0.42
Anxiety/depression 1.71 1.50 1.62 − 0.65 0.21
EQ VAS 73.00 75.19 14.25 − 13.10 − 2.17
EQ-5D-5L index score 0.76 0.80 0.11 − 0.43 − 0.04
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EQ-5D-5L than in the AA. This may indicate that the AA 
does not provide much added information and therefore 
does not warrant the additional effort. However, this finding 
seems in contrast to most participants clearly favouring AA 
over one-time assessment because they believed it captured 
important information about their health. An explanation 
may be that they regard the variability and pattern of health 
fluctuations as relevant over and above the average level of 
impairment. Indeed, all six EQ-5D-AA items showed vari-
ation in most participants, and the patterns were also quite 
different: some participants had highly stable values, while 
others showed considerable fluctuation. Detecting these pat-
terns may be of additional value in understanding a person’s 
health status, comparable to findings that emotion variabil-
ity has added value next to average emotion intensity when 
predicting well-being [33, 34]. However, these quantitative 
findings were exploratory only and need confirmation in a 
larger sample.
The EQ-5D-AA items ask retrospectively to the previ-
ous assessment; thereby, covering the complete assess-
ment period (except for the night where two items were not 
applicable, usual activities and self-care). This approach 
is called proximal intensive assessment or complete cover-
age [15, 31]. In contrast, a sampling strategy would assess 
a—usually random—sample of moments only, which are 
taken to be representative for all moments within the sam-
pling period. Such a strictly momentary approach would be 
applicable to the EQ-5D-5L dimensions of pain/discomfort 
and anxiety/depression: Both are states of mind that have 
some intensity at any given (waking) moment, including a 
possible intensity of zero. However, for some dimensions a 
momentary approach is not appropriate as they do not apply 
to most moments. This is especially true for the self-care 
dimension (because most of the day, no washing or dress-
ing is needed), and to a lesser extent probably also for usual 
activities and mobility. However, the coverage approach used 
here also comes with disadvantages: recall bias is possible, 
and respondents still have to build an average value for the 
respective—albeit short—time period.
For the exploratory analyses, we calculated an index 
score for the seven-day AA period by first determining the 
score for each day, using the respective highest score of each 
item, and then averaging over days. It was not possible to 
determine a score for each time point because only three 
out of five items were assessed three times a day. However, 
with this calculation, scores will be the same regardless of 
whether an impairment was present during the complete 
day or only parts of it. As an alternative, the median or 
mode score of all item values of the week could be used for 
index score calculation. In addition, one could determine 
seven-day fluctuation scores, using variability or instability 
parameters [33–35]. Which of all these scores carry most 
information on patient-relevant aspects of health and/or are 
predictive of future health outcomes, needs to be evaluated 
with larger samples. Score calculation is further complicated 
by the missing data, which are very common in AA due to 
the high number of assessments and have also been found 
in the majority of our participants. Imputing missing values 
using statistical techniques, such as multiple imputation is 
recommended [36].
We would not recommend the EQ-5D-AA for use as a 
utility measure in health-economic evaluations for several 
reasons. One, existing valuation sets for the EQ-5D-5L can-
not be used for an AA version; instead, specific preference 
elicitation studies would be needed which require large rep-
resentative samples. Two, AA comes with higher respondent 
burden and also logistic effort than the standard EQ-5D-5L 
assessment. As health-economic evaluation often draws on 
the data from clinical trials, it is probably unrealistic that 
the additional effort of an AA will be taken in these studies.
Larger, subsequent studies also need to evaluate psycho-
metric properties of the EQ-5D-AA as compared to the EQ-
5D-5L and confirm its feasibility. They should use a stand-
alone AA application that is compatible with both Android 
and iOs so that most participants can use their own mobile 
phone, probably reducing missing values. Finally, it should 
be evaluated whether and under which circumstances (e.g., 
one’s job and family situation) people would also be will-
ing to complete the AA for a longer period of time than 
tested here—for example for monitoring purposes in clini-
cal practice. This is of particular importance as our sample 
was small and probably also subject to selection bias in that 
only people who were willing to complete an AA took part.
If the EQ-5D-AA will prove valid and reliable, it can be 
used in future research, but also by individual PwMS self-
tracking their health; some of our participants mentioned 
this to be an interesting option. Such data might also support 
patient-clinician communication on symptom dynamics and 
management, for example for activity planning and sympto-
matic treatment applications: Whether such use in clinical 
care is feasible and useful would need to be addressed in 
additional research, also investigating feasibility and useful-
ness from the health providers’ perspective.
A strength of this study was its iterative approach to 
AA development with subsequent waves of real-life test-
ing, debriefing and adaptation. This approach may also 
be suited for AA development in other health conditions. 
Furthermore, our multidisciplinary research team included 
experts on PROMs and electronic PRO assessment, mem-
bers of the EuroQol group, and a clinician specialised in MS 
care, each contributing their unique perspective on the AA 
development.
While our study sample was heterogeneous with regard to 
gender, age, disease duration, and both cognitive and subjec-
tive health impairment, it should be considered a limitation 
that most participants were from Hamburg, Germany, and 
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people with lower education were underrepresented. It will 
therefore be important to include PwMS from this subgroup 
as well as people from other regions, including rural areas, 
in subsequent validation studies. Owing to the small sample, 
which also represents a limitation, the exploratory quantita-
tive analyses can only give a hint on possible associations 
and patterns in EQ-5D-AA data that may warrant investiga-
tion in follow-up studies.
Conclusion
This study suggests that an one-week AA of the EQ-5D-5L 
can capture within-day and day-to-day fluctuations in sub-
jective health and was feasible in people with MS. Patients 
stated that the EQ-5D-AA can provide important informa-
tion on their health beyond what is captured by the EQ-
5D-5L standard version.
Supplementary Information The online version contains supplemen-
tary material available at https ://doi.org/10.1007/s1113 6-021-02802 -8.
Acknowledgements We thank all participants of this study. We grate-
fully acknowledge the student assistants Antonia Newi and Lena Hirsch 
for their help in conducting this study. The authors thank the Scientific 
Communication Team of the IVDP, in particular Merle Twesten and 
Mario Gehoff, for copy editing. This work has been presented at the 
26th Annual Conference of the International Society for Quality of 
Life Research 2019, San Diego, CA, USA, and at the 18. Deutscher 
Kongress für Versorgungsforschung (German Congress for Health Care 
Research) 2019, Berlin, Germany.
Author contributions All authors— Conceptualisation and methodol-
ogy, data analysis, writing—review and editing. Christine Blome—data 
collection, writing—original draft preparation. Christine Blome, Jill 
Carlton, John Brazier— funding acquisition.
Funding Open Access funding enabled and organized by Projekt 
DEAL. This research was funded by the EuroQol Research Founda-
tion, EQ Project 201660. The views expressed by the authors in this 
publication do not necessarily reflect the views of the EuroQol Group.
Data availability The data that support the findings of this study and 
the SPSS code are available from the corresponding author upon rea-
sonable request.
Declarations 
Conflict of interest The University of Sheffield was paid by the Euro-
Qol Research Foundation for the time of JC and JB. The University 
Medical Center Hamburg-Eppendorf was paid by the EuroQol Re-
search Foundation for the time of CB and CH. MFJ has received re-
search funding from the EuroQol Research Foundation for this project. 
AL has received research funding from the EuroQol Research Founda-
tion for this project. MO has no conflict of interest to declare.
Ethical approval The study was performed in accordance with the June 
1964 Declaration of Helsinki. The Ethics Committee of the Hamburg 
Chamber of Physicians provided ethical approval (reference PV5721). 
All participants gave written informed consent.
Informed consent Not applicable.
Copyright notes EQ-5D™ is a trade mark of the EuroQol Research 
Foundation. EQ-5D was modified by the authors with permission by 
the EuroQol Research Foundation. Reproduction of this version is not 
allowed. For reproduction, use or modification of the EQ-5D (any ver-
sion), please register your study by using the online EQ registration 
page: www.euroq ol.org.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018). Multi-
ple sclerosis. New England J Med, 378(2), 169–118.
 2. Faissner, S., & Gold, R. (2019). Progressive multiple sclerosis: 
latest therapeutic developments and future directions. Therapeutic 
Adv Neurol Disorders, 25(12), 1756286419878323.
 3. Galea, I., Ward-Abel, N., & Heesen, C. (2015). Relapse in multi-
ple sclerosis. British Med J, 350, h1765.
 4. Kratz, A. L., Murphy, S. L., & Braley, T. J. (2017). Ecological 
momentary assessment of pain, fatigue, depressive, and cogni-
tive symptoms reveals significant daily variability in multiple 
sclerosis. Archives Physical Medicine Rehabilitation, 98(11), 
2142–2150.
 5. Heine, M., van den Akker, L. E., Blikman, L., Hoekstra, T., van 
Munster, E., Verschuren, O., et al. (2016). Real-time assessment 
of fatigue in patients with multiple sclerosis: how does it relate 
to commonly used self-report fatigue questionnaires? Archives of 
Physical Medicine Rehabilitation, 97(11), 1887–1894.
 6. Kasser, S. L., Goldstein, A., Wood, P. K., & Sibold, J. (2017). 
Symptom variability, affect and physical activity in ambulatory 
persons with multiple sclerosis: Understanding patterns and time-
bound relationships. Disability Health J, 10(2), 207–213.
 7. Powell, D. J. H., Liossi, C., Schlotz, W., & Moss-Morris, R. 
(2017). Tracking daily fatigue fluctuations in multiple sclerosis: 
ecological momentary assessment provides unique insights. Jour-
nal of Behavioral Medicine, 40(5), 772–783.
 8. Kratz, A. L., Murphy, S. L., & Braley, T. J. (2017). Pain, fatigue, 
and cognitive symptoms are temporally associated within but not 
across days in multiple sclerosis. Archives Physical Med Rehabili-
tation, 98(11), 2151–2159.
 9. Stone, A. A., & Shiffman, S. (1994). Ecological momentary 
assessment (EMA) in behavioral medicine. Annals Behav Med, 
16(3), 199–202.
 10. Bolger, N., & Laurenceau, J.-P. (2013). Intensive longitudinal 
methods: An introduction to diary and experience sampling 
research. New York, NY: Guilford Press.
 Quality of Life Research
1 3
 11. Schwarz, N. (Ed.). (2007). Retrospective and concurrent self-
reports: The rationale for real-time data capture. New York, NY: 
Oxford University Press.
 12. Schwartz, C. E., & Sprangers, M. A. (1999). Methodologi-
cal approaches for assessing response shift in longitudinal 
health-related quality-of-life research. Social Sci Med, 48(11), 
1531–1548.
 13. Schneider, S., & Stone, A. A. (2016). Ambulatory and diary meth-
ods can facilitate the measurement of patient-reported outcomes. 
Quality Life Res, 25(3), 497–506.
 14. Mareva, S., Thomson, D., Marenco, P., Estal Muñoz, V., Ott, 
C. V., Schmidt, B., et al. (2016). Study protocol on ecological 
momentary assessment of health-related quality of life using a 
smartphone application. Frontiers Psychol, 7, 1086.
 15. Carlson, E. B., Field, N. P., Ruzek, J. I., Bryant, R. A., Dalenberg, 
C. J., Keane, T. M., et al. (2016). Advantages and psychometric 
validation of proximal intensive assessments of patient-reported 
outcomes collected in daily life. Quality Life Res, 25(3), 507–516.
 16. Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Par-
kin, D., et al. (2011). Development and preliminary testing of the 
new five-level version of EQ-5D (EQ-5D-5L). Quality Life Res, 
20(10), 1727–1736.
 17. Devlin, N. J., & Brooks, R. (2017). EQ-5D and the EuroQol 
group: past, present and future. Applied Health Economics Health 
Policy, 15(2), 127–137.
 18. Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, 
M., Scalone, L., et al. (2013). Measurement properties of the EQ-
5D-5L compared to the EQ-5D-3L across eight patient groups: a 
multi-country study. Quality Life Res, 22(7), 1717–1727.
 19. Buchholz, I., Janssen, M. F., Kohlmann, T., & Feng, Y. S. (2018). 
A systematic review of studies comparing the measurement prop-
erties of the three-level and five-level versions of the EQ-5D. 
PharmacoEconomics, 36(6), 645–661.
 20. Konnopka, A., & König, H. H. (2017). The “no problems”-prob-
lem: an empirical analysis of ceiling effects on the EQ-5D 5L. 
Quality Life Res, 26(8), 2079–2084.
 21. Kuspinar, A., & Mayo, N. E. (2014). A review of the psychometric 
properties of generic utility measures in multiple sclerosis. Phar-
macoEconomics, 32(8), 759–773.
 22. Efthymiadou, O., Mossman, J., & Kanavos, P. (2019). Health 
related quality of life aspects not captured by EQ-5D-5L: Results 
from an international survey of patients. Health Policy, 123(2), 
159–165.
 23. Jones, K. H., Ford, D. V., Jones, P. A., John, A., Middleton, R. 
M., Lockhart-Jones, H., et al. (2013). How people with multiple 
sclerosis rate their quality of life: an EQ-5D survey via the UK 
MS register. PLoS ONE, 8(6), e65640.
 24. Hemmett, L., Holmes, J., Barnes, M., & Russell, N. (2004). What 
drives quality of life in multiple sclerosis? QJM: An International 
Journal of Medicine, 97(10), 671–676.
 25. Kerr, C., Lloyd, E. J., Kosmas, C. E., Smith, H. T., Cooper, J. 
A., Johnston, K., et al. (2016). Health-related quality of life in 
Parkinson’s: impact of ‘off’ time and stated treatment preferences. 
Quality Life Res, 25(6), 1505–1515.
 26. Maes, I. H. L., Delespaul, P. A. E. G., Peters, M. L., White, M. P., 
van Horn, Y., Schruers, K., et al. (2015). Measuring health-related 
quality of life by experiences: the experience sampling method. 
Value Health, 18(1), 44–51.
 27. Kim, H., Sefcik, J. S., & Bradway, C. (2017). Characteristics of 
qualitative descriptive studies: a systematic review. Res Nursing 
Health, 40(1), 23–42.
 28. Sullivan, J., Edgeley, K., & Dehoux, E. (1990). A survey of multi-
ple sclerosis. part I: perceived cognitive problems and compensa-
tory strategy used. Canadian J Rehabilitation, 4, 99–105.
 29. Malterud, K., Siersma, V. D., & Guassora, A. D. (2016). Sample 
size in qualitative interview studies: guided by information power. 
Qualitative Health Res, 26(13), 1753–1760.
 30. Ludwig, K., Graf von der Schulenburg, J.-M., & Greiner, W. 
(2018). German value set for the EQ-5D-5L. PharmacoEconom-
ics, 36(6), 663–674.
 31. Shiffman, S. (2007). Designing protocols for ecological momen-
tary assessment. In A. Stone, S. Shiffman, A. Atienza, & L. Nebe-
ling (Eds.), The science of real-time data capture: Self-reports in 
health research. New York, NY: Oxford University Press.
 32. Fuller-Tyszkiewicz, M., Skouteris, H., Richardson, B., Blore, J., 
Holmes, M., & Mills, J. (2013). Does the burden of the experi-
ence sampling method undermine data quality in state body image 
research? Body Image, 10(4), 607–613.
 33. Houben, M., van den Noortgate, W., & Kuppens, P. (2015). The 
relation between short-term emotion dynamics and psychologi-
cal well-being: A meta-analysis. Psychological Bulletin, 141(4), 
901–930.
 34. Dejonckheere, E., Mestdagh, M., Houben, M., Rutten, I., Sels, L., 
Kuppens, P., et al. (2019). Complex affect dynamics add limited 
information to the prediction of psychological well-being. Nat 
Human Behav, 3(5), 478–491.
 35. Topp, J., Andrees, V., Heesen, C., Augustin, M., & Blome, C. 
(2019). Recall of health-related quality of life: how does memory 
affect the SF-6D in patients with psoriasis or multiple sclerosis? A 
prospective observational study in Germany. British Med J Open, 
9(11), e032859.
 36. Black, A., Harel, O., & Matthews, G. (2012). Techniques for Ana-
lyzing Intensive Longitudinal Data with Missing Values. In M. R. 
Mehl & T. S. Conner (Eds.), Handbook of research methods for 
studying daily life. New York: The Guilford Press.
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
